Research in a commonly used animal model suggests CBD could help in the management and progression of Parkinson’s and other motor neuron diseases.

In a 28-day study at Italy’s IRCCS Mondino Foundation, CBD-treated animals showed increased survival of the nerve cells normally impacted by Parkinson’s disease, along with recovery of motor performance.

The study contributes to a growing body of evidence for using CBD medicines in managing the symptoms and slowing the progression of Parkinson’s, with research also underway into its potential therapeutic benefits for other motor neuron diseases.

Gold Coast University Hospital is currently recruiting patients with motor-neurone disease or amyotrophic lateral sclerosis for a trial using Bod’s MediCabilis product, which was also used in the Italian study.

Bod CEO Jo Patterson said: “We are excited by this new research and the discovery of the mode of action of CBD in Parkinson’s disease.”

Around 212,000 people live with Parkinson’s in Australia.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...